Improve Medical Instruments Hits Day Low of CNY 6.97 Amid Price Pressure

Improve Medical Instruments Co., a small-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline of 7.83% on March 23, 2026. The stock reached an intraday low of CNY 6.97, reflecting a challenging trading environment. Over the past week, the stock has dropped 16.45%, and its monthly performance shows a decrease of 15.14%. Despite a year-over-year gain of 17.47%, the company's long-term growth metrics raise concerns. Net sales have contracted at an annual rate of 8.20%, and operating profit has seen a dramatic decline of 185.09% over the last five years. The company's financial health is further illustrated by a low Return on Capital Employed (ROCE) of 1.84% and a Return on Equity (ROE) of -4.75%. With a market capitalization of CNY 2,103 million, Improve Medical Instruments Co. is navigating a complex landscape characterized by high debt levels and a debt-to-equity ratio of 0.06. As the company continues to report mixed financial results, its performance remains under scrutiny within the broader market context.